Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA14 | Q9ULX7 | 4/20 | 0.40 |
| ▸ | CA12 | O43570 | 3/20 | 0.40 |
| ▸ | CA1 | P00915 | 2/20 | 0.40 |
| ▸ | CA7 | P43166 | 1/20 | 0.40 |
| ▸ | CA2 | P00918 | 2/20 | 0.38 |
| ▸ | CPB2 | Q96IY4 | 1/20 | 0.30 |
| ▸ | CTSK | P43235 | 1/20 | 0.30 |
| ▸ | BIRC2 | Q13490 | 1/20 | 0.30 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.30 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.30 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.30 |
| ▸ | NCOR2 | Q9Y618 | 1/20 | 0.30 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24983946 | 0.81 | CA14 (0.41) | CA14CA12CA1CA7CA2 | |
| SCHEMBL4547485 | 0.81 | CA14 (0.38) | CA14CA12CA1CA7CA2 | |
| SCHEMBL27536080 | 0.79 | CA14 (0.37) | CA14CA12CA1CA2CTSK | |
| SCHEMBL25411706 | 0.78 | CA14 (0.33) | CA14CA12CA1CA7CA2 | |
| SCHEMBL3469119 | 0.76 | CA14 (0.46) | CA14CA12CA1CA7CA2 | |
| SCHEMBL19457048 | 0.74 | CA14 (0.36) | CA14CA12CA1CA7HDAC1 | |
| SCHEMBL25124098 | 0.74 | CA14 (0.39) | CA14CA12CA1CA7CA2 | |
| SCHEMBL14537630 | 0.74 | CA12 (0.41) | CA14CA12CA1CA7CA2 | |
| SCHEMBL19663961 | 0.74 | CA14 (0.40) | CA14CA12CA1CA7CA2 | |
| SCHEMBL13534084 | 0.72 | HDAC6 (0.35) | CA14CA12CA1CA7CA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023135528-A1 | HETEROALICYCLIC DERIVATIVES AND THEIR USE IN THE TREATMENT OF CNS DISORDERS | SUVEN LIFE SCIENCES LIMITED (IN) | 2023-07-20 | — | — | WO | disclosed |